NASDAQ:CLGN CollPlant Biotechnologies Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. $8.20 +0.20 (+2.50%) (As of 07/1/2022 03:04 PM ET) Add Compare Share Today's Range$7.95▼$8.2050-Day Range$8.00▼$10.3252-Week Range$7.50▼$23.00Volume251 shsAverage Volume37,705 shsMarket Capitalization$90.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CLGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CollPlant Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address CLGN Stock Forecast (MarketRank)Overall MarketRank™0.90 out of 5 starsMedical Sector1289th out of 1,429 stocksSurgical Appliances & Supplies Industry27th out of 30 stocksAnalyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for CollPlant Biotechnologies. Previous Next 3.9 Community Rank Outperform VotesCollPlant Biotechnologies has received 129 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCollPlant Biotechnologies has received 93 “underperform” votes. (Add your “underperform” vote.)Community SentimentCollPlant Biotechnologies has received 58.11% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about CollPlant Biotechnologies and other stocks. Vote “Outperform” if you believe CLGN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CLGN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCollPlant Biotechnologies does not currently pay a dividend.Dividend GrowthCollPlant Biotechnologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CollPlant Biotechnologies insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for CollPlant Biotechnologies are expected to grow in the coming year, from ($0.34) to $3.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CollPlant Biotechnologies is -6.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CollPlant Biotechnologies is -6.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCollPlant Biotechnologies has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About CollPlant Biotechnologies (NASDAQ:CLGN)CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.Read More CLGN Stock News HeadlinesJune 29, 2022 | finance.yahoo.comCollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine StudyMay 26, 2022 | finance.yahoo.comCollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial ResultsMay 21, 2022 | finance.yahoo.comThe 22% return this week takes CollPlant Biotechnologies' (NASDAQ:CLGN) shareholders three-year gains to 141%April 25, 2022 | finance.yahoo.comCollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and ScreeningApril 13, 2022 | finance.yahoo.comCollPlant To Present at the Aesthetics Innovation Summit 2022April 9, 2022 | finance.yahoo.comIs CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shareholder Ownership Skewed Towards Insiders?March 25, 2022 | benzinga.comCollPlant Biotechnologies Reports FY21 Sales $15.6M Vs. $6.1M YoYMarch 24, 2022 | finance.yahoo.comCollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial ResultsFebruary 16, 2022 | finance.yahoo.comCELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologiesFebruary 3, 2022 | finance.yahoo.comA Look At The Intrinsic Value Of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN)January 16, 2022 | nasdaq.comCollPlant Biotechnologies Ltd New Shares Near 52-Week Low - Market MoverDecember 28, 2021 | nasdaq.comCollPlant Biotechnologies Ltd New Shares Close the Day 35.3% Higher - Daily WrapDecember 5, 2021 | finance.yahoo.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?See More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CLGN CUSIPN/A CIK1631487 Webwww.collplant.com Phone972732325600Fax972-73-232-5602Employees52Year FoundedN/ACompany Calendar Last Earnings5/26/2022Today7/01/2022Next Earnings (Estimated)8/18/2022Fiscal Year End12/31/2022Profitability EPS (Most Recent Fiscal Year)($1.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$240 thousand Net Margins-1,138.94% Pretax Margin-1,138.94% Return on Equity-29.53% Return on Assets-26.36% Debt Debt-to-Equity RatioN/A Current Ratio16.32 Quick Ratio15.83 Sales & Book Value Annual Sales$15.64 million Price / Sales5.81 Cash FlowN/A Price / Cash FlowN/A Book Value$4.19 per share Price / Book1.96Miscellaneous Outstanding Shares11,086,000Free FloatN/AMarket Cap$90.91 million OptionableNot Optionable BetaN/A CollPlant Biotechnologies Frequently Asked Questions How has CollPlant Biotechnologies' stock performed in 2022? CollPlant Biotechnologies' stock was trading at $16.36 at the start of the year. Since then, CLGN stock has decreased by 49.9% and is now trading at $8.20. View the best growth stocks for 2022 here. When is CollPlant Biotechnologies' next earnings date? CollPlant Biotechnologies is scheduled to release its next quarterly earnings announcement on Thursday, August 18th 2022. View our earnings forecast for CollPlant Biotechnologies. How were CollPlant Biotechnologies' earnings last quarter? CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) released its quarterly earnings data on Thursday, May, 26th. The company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by $0.22. The company had revenue of $0.07 million for the quarter, compared to analysts' expectations of $2.74 million. CollPlant Biotechnologies had a negative net margin of 1,138.94% and a negative trailing twelve-month return on equity of 29.53%. View CollPlant Biotechnologies' earnings history. Who are CollPlant Biotechnologies' key executives? CollPlant Biotechnologies' management team includes the following people: Mr. Yehiel Tal, Chief Exec. Officer (Age 70, Pay $970k)Mr. Eran Rotem CPA, Deputy CEO & CFO (Age 54, Pay $692k)Dr. Ilana Belzer, Chief Operations Officer (Age 62, Pay $317k)Prof. Oded Shoseyov, Founder & Chief Scientist (Age 66)Ms. Michal Roytman, VP of Sales & Marketing (Age 37)Ms. Hadas Dreiher Horowitz, VP of HR (Age 45) Who are some of CollPlant Biotechnologies' key competitors? Some companies that are related to CollPlant Biotechnologies include Sanara MedTech (SMTI), Lakeland Industries (LAKE), United Health Products (UEEC), Milestone Scientific (MLSS), Milestone Scientific (MLSS), Conformis (CFMS), ReWalk Robotics (RWLK), Alpha Pro Tech (APT), Alpha Pro Tech (APT), Sientra (SIEN), Invacare (IVC), Nutriband (NTRB), Eargo (EAR), Predictive Oncology (POAI) and Surgalign (SRGA). View all of CLGN's competitors. What other stocks do shareholders of CollPlant Biotechnologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other CollPlant Biotechnologies investors own include Genocea Biosciences (GNCA), Boingo Wireless (WIFI), Allena Pharmaceuticals (ALNA), Advanced Micro Devices (AMD), Ampio Pharmaceuticals (AMPE), Energy Transfer (ET), HTG Molecular Diagnostics (HTGM), OPKO Health (OPK), Ovid Therapeutics (OVID) and Primo Water (PRMW). When did CollPlant Biotechnologies IPO? (CLGN) raised $22 million in an initial public offering (IPO) on Friday, December 9th 2016. The company issued 3,500,000 shares at a price of $6.23 per share. Ladenburg Thalmann acted as the underwriter for the IPO and Roth Capital Partners was co-manager. What is CollPlant Biotechnologies' stock symbol? CollPlant Biotechnologies trades on the NASDAQ under the ticker symbol "CLGN." How do I buy shares of CollPlant Biotechnologies? Shares of CLGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is CollPlant Biotechnologies' stock price today? One share of CLGN stock can currently be purchased for approximately $8.20. How much money does CollPlant Biotechnologies make? CollPlant Biotechnologies (NASDAQ:CLGN) has a market capitalization of $90.91 million and generates $15.64 million in revenue each year. The company earns $240 thousand in net income (profit) each year or ($1.25) on an earnings per share basis. How many employees does CollPlant Biotechnologies have? CollPlant Biotechnologies employs 52 workers across the globe. How can I contact CollPlant Biotechnologies? CollPlant Biotechnologies' mailing address is 4 OPPENHEIMER ST. 11TH FLOOR, REHOVOT L3, 74140. The official website for CollPlant Biotechnologies is www.collplant.com. The company can be reached via phone at 972732325600, via email at [email protected], or via fax at 972-73-232-5602. This page (NASDAQ:CLGN) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
